NovoCodex - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

NovoCodex

company

Summary
Funding Rounds
Investors

About

NovoCodex has been engaged in the business of genetic engineering, and cell culture, among others.

Highlights

Total Funding Amount

Details

Last Funding Type: Series A
Last Funding Money Raised: ¥400M
Industries: Clinical Trials,Health Care,Product Research
Founded date: Jan 1, 2015
Operating Status: Active

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

¥400M

NovoCodex has raised a total of ¥400M in funding over 2 rounds. Their latest funding was raised on Mar 19, 2021 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Mar 19, 2021	Series A	¥400M	1	Lilly Asia Ventures	—	Detail

Investors

Number of Lead Investors

Number of Investors

1

1

NovoCodex is funded by 1 investors. Lilly Asia Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Lilly Asia Ventures	Yes	Series A